WORCESTER, Mass.--(BUSINESS WIRE)--Agilux Laboratories, a leading provider of Drug Metabolism and Pharmacokinetics (DMPK) services to pharmaceutical and biotechnology firms, announced today that it has undergone a significant space expansion of its in vivo pharmacokinetics services to support clients’ demands and increased service requirements. This space expansion will allow Agilux to significantly increase its capacity and volume while maintaining its historically fast study starts.
Help employers find you! Check out all the jobs and post your resume.
